ArticleBMC neurology2026

A novel limited-dose C5 inhibitor add-on as rescue therapy for refractory NMOSD attacks: a practical alternative to conventional multi-dose regimens.

Dianjia Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.